Related Experiment Video
Updated: Jun 1, 2026

Shunt Surgery, Right Heart Catheterization, and Vascular Morphometry in a Rat Model for Flow-induced Pulmonary Arterial Hypertension
Published on: February 11, 2017
Change in left ventricular geometry during antihypertensive treatment in children with primary hypertension
Joanna Sladowska-Kozłowska1, Mieczysław Litwin, Anna Niemirska
1Department of Nephrology and Arterial Hypertension, The Children's Memorial Health Institute, Warsaw, Poland.
Insights
In children with primary hypertension, left ventricular (LV) geometry changes are linked to obesity and insulin resistance. Reducing abdominal obesity and improving insulin sensitivity are key to normalizing LV geometry.
Area of Science:
- Pediatric Cardiology
- Cardiovascular Research
- Metabolic Syndrome
Background:
- Left ventricular (LV) geometry is crucial in adult hypertension.
- Understanding LV geometry changes in pediatric primary hypertension (PH) is vital.
- Metabolic and anthropometrical factors may influence LV geometry in hypertensive children.
Purpose of the Study:
- To analyze changes in LV geometry after one year of antihypertensive treatment in children with PH.
- To identify determinants of LV geometry changes, focusing on metabolic abnormalities and anthropometrical parameters.
- To assess the impact of treatment on LV geometry in pediatric PH.
Main Methods:
- Assessed LV geometry and biochemical parameters in 86 children with newly diagnosed PH before and after 12 months of treatment.
- Classified baseline LV geometry into normal geometry (NG), concentric remodeling (CR), concentric hypertrophy (CH), and eccentric hypertrophy (EH).
- Analyzed the relationship between LV geometry, visceral obesity, and metabolic parameters like the triglycerides to high density lipoprotein cholesterol (TG/HDL) ratio.
Main Results:
- At baseline, 48.9% had NG, 4.6% CR, 9.3% CH, and 37.2% EH. Patients with CH and EH showed greater visceral obesity.
- After 12 months of antihypertensive treatment, the prevalence of EH decreased significantly (37.2% to 18.6%), while CH prevalence remained unchanged.
- A decrease in the triglycerides to high density lipoprotein cholesterol (TG/HDL) ratio was the main predictor of decreased relative wall thickness (RWT) and normalization of LV geometry.
Conclusions:
- LV geometry in adolescents with PH is associated with central obesity and insulin resistance.
- Decreased abdominal obesity and improved insulin resistance are critical for normalizing LV geometry.
- Concentric hypertrophy (CH) demonstrates a lower potential for normalization compared to other LV geometry patterns.
Abstract:
The pattern of the left ventricle (LV) has important significance in adults with hypertension. The aim of the present study was to analyze changes and determinants of LV geometry after 1 year of antihypertensive treatment in children with primary hypertension (PH) in relation to metabolic abnormalities and anthropometrical parameters. In 86 children (14.1 ± 2.4 years) with newly diagnosed PH, LV geometry and biochemical parameters before and after 12 months of standard antihypertensive therapy were assessed. At baseline, normal LV geometry (NG) was found in 42 (48.9%), concentric remodeling (CR) in 4 (4.6%), concentric hypertrophy (CH) in 8 (9.3%), and eccentric hypertrophy (EH) in 32 (37.2%) patients. The prevalence of NG in patients with severe hypertension was significantly lower than in patients with ambulatory hypertension. There were no differences in dipping status in relation to LV geometry. Patients with CH and EH were more viscerally obese than patients with NG. Patients with CH had higher diastolic blood pressure in comparison with EH patients (p < 0.05). The main predictor of relative wall thickness (RWT) was the triglycerides to high density lipoprotein cholesterol (TG/HDL) ratio (R(2 ) = 0.319, β = 0.246, p = 0.004). Patients received 12 months of antihypertensive treatment, either lifestyle modification only (n = 37) or lifestyle modification plus antihypertensive medications (n = 49) if severe ambulatory hypertension or target organ damage were present. After 12 months of treatment the prevalence of EH (37.2% vs 18.6%, p = 0.003) decreased but prevalence of CH did not change. Patients in whom RWT decreased also decreased waist circumference and TG/HDL; the main predictor of RWT decrease was a decrease of the TG/HDL ratio (β = 0.496, R (2) = 0.329, p = 0.002). In adolescents with PH, LV geometry is related to central obesity and insulin resistance. Decrease of abdominal obesity and insulin resistance are the most important predictors of normalization of LV geometry, however CH has lower potential to normalize LV geometry.
More Related Videos
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure II: Pathophysiology
Aortic Regurgitation III: Medical Management
Mitral Regurgitation I: Introduction
Mitral Stenosis I: Introduction

